1332 results
New approaches in aortic regurgitation
16 Nov 2025 – From PCR London Valves 2025
Explore new diagnostic and therapeutic approaches for managing aortic regurgitation. This session covers imaging modalities, guideline-directed patient selection, current transcatheter treatment techniques, and emerging TAVI technologies designed specifically for non-calcific aortic valve pathology.
Curious TAVI scenarios: from valve-in-valve challenges to life-saving emergency TAVI
16 Nov 2025 – From PCR London Valves 2025
This session presents a series of challenging and unusual TAVI cases, addressing complex scenarios such as persistent gradients after valve-in-valve procedures, advanced sealing techniques for nodules, innovative snare methods, emergency TAVI following diagnostic catheterisation, combined aortic valve and aorta interventions, and the crucial role of echocardiography...
Emergency transcatheter valve interventions: alternative therapy or bridge to surgery?
16 Nov 2025 – From PCR London Valves 2025
This session offers a compelling case-based exploration of emergency transcatheter valve interventions, demonstrating their potential as life-saving alternatives or bridges to surgery in high-risk patients. Through detailed clinical scenarios including cardiogenic shock, acute papillary muscle rupture, and severe aortic regurgitation from infective endocarditis, participants gain practical...
Challenging TAVI
16 Nov 2025 – From PCR London Valves 2025
This session addresses the complexities encountered in transcatheter aortic valve implantation (TAVI) in challenging anatomical settings. It reviews management of bicuspid valves with calcification, horizontal aorta, coronary artery anomalies, and navigation of difficult angles. Case studies illustrate techniques to optimize commissural alignment and strategies to address...
TAVI: unusual complications
16 Nov 2025 – From PCR London Valves 2025
This session examines rare and unusual complications arising from TAVI procedures. Topics include early recognition and management of frozen leaflets, ventricular septal perforation post-valve-in-valve TAVI, acute leaflet dysfunction, aorto-ventricular fistula formation, and percutaneous closure techniques for fistulas involving the right coronary sinus and right ventricle, emphasizing...
Align for the future with next gen Myval transcatheter heart valve series
16 Nov 2025 – From PCR London Valves 2025
Discover how the latest Myval transcatheter heart valve (THV) innovations are shaping TAVI outcomes. This PCR London Valves 2025 session highlights the clinical evidence behind the next-gen Myval THV series, best practices for implantation, and upcoming innovations set to improve patient care. Learn step-by-step techniques for deploying Myval...
Hotline - TAVI - Part 1
16 Nov 2025 – From PCR London Valves 2025
This comprehensive session examines the latest evidence and clinical trial data on TAVI, including comparisons of balloon-expandable versus self-expanding valves in failed bioprostheses, techniques to reduce coronary obstruction risk, and real-world outcomes across diverse populations. Cost-effectiveness analyses and longitudinal studies further inform best practices for optimizing...
Valve interventions in congenital heart disease
16 Nov 2025 – From PCR London Valves 2025
This session presents complex valve interventions in congenital heart disease, highlighting challenging cases such as positional hypoxaemia due to iatrogenic atrial defects, navigating residual shunts after PFO closure, and transcatheter pulmonary valve replacement in native right ventricular outflow tracts without pre-stenting. It also examines an intriguing...
Day case TAVI - The future standard of care for most TAVI patients
16 Nov 2025 – From PCR London Valves 2025
Examining the UK experience, this session discusses the emerging standard of day case TAVI and its potential application across Europe. It evaluates patient-centered risks and benefits, operational requirements, and the evolving role of clinical valve coordinators to facilitate safe and efficient day case pathways for TAVI...
TAVI in aortic regurgitation
16 Nov 2025 – From PCR London Valves 2025
This session addresses the challenges and innovations in transcatheter aortic valve implantation (TAVI) for aortic regurgitation. It covers complex clinical scenarios such as severe regurgitation post-endocarditis, alternative access routes complicated by prosthesis embolisation, and the use of dedicated TAVI devices in non-tricuspid valves. The session also...
TAVI-in-TAVI
16 Nov 2025 – From PCR London Valves 2025
This session explores the nuanced field of TAVI-in-TAVI procedures, focusing on valve durability considerations between bovine and porcine valves, strategies for redo TAVI post valve-in-valve, and advanced interventions to secure coronary flow such as inter-valvular stenting. It highlights complex anatomical challenges including aberrant coronary origins and...
Getting the full potential of the supra-annular valve in a changing landscape
16 Nov 2025 – From PCR London Valves 2025
This session explores the evolving landscape of transcatheter aortic valve implantation (TAVI) with a focus on supra-annular valve technology. It covers techniques for achieving commissural alignment, considerations for small aortic annuli, and advantages in treating bicuspid aortic valve disease, supported by clinical data and illustrative cases.
Meet the masters: complex TAVI
16 Nov 2025 – From PCR London Valves 2025
This session offers an in-depth exploration of complex Transcatheter Aortic Valve Implantation (TAVI) procedures, emphasizing practical aspects crucial for daily clinical practice. Expert TAVI operators share their extensive experience, providing valuable tips and tricks on case selection, procedural strategies, and managing complications to optimize patient outcomes.
Patient-tailored TAVI in bicuspid and tricuspid aortic stenosis
16 Nov 2025 – From PCR London Valves 2025
This session focuses on patient-tailored TAVI strategies for bicuspid and tricuspid aortic stenosis. It reviews recent comparative studies of TAVI devices, discusses the development of individualized TAVI programs for tricuspid aortic stenosis patients, and provides guidance on selecting optimal devices for those with bicuspid aortic valve...
PARTNER 3: transcatheter or surgical aortic-valve replacement in low-risk patients at 7 years
14 Nov 2025
At 7 years, low-risk patients affected by severe symptomatic aortic valve stenosis 1:1 randomly treated by SAPIEN 3 TAVI or surgery showed similar clinical outcomes and late valve durability
Reviewer
Reviewer
Treating severe restenosis of a 20-mm balloon-expanding valve after a transapical approach with a risk of coronary obstruction
05 Nov 2025
In this challenging redo TAVI case, an 87-year-old woman presented with severe bioprosthetic valve restenosis and advanced heart failure symptoms, eight years after a previous transapical implantation.
Her frailty, prior surgical approach, and complex anatomy—with low coronary heights and a stent frame extending beyond the sinotubular junction—posed...
Author
Author
Author
Author
Author
Author
Long-term follow-up of the PARTNER 3 Low-Risk randomised trial: seven-year clinical and echocardiographic outcomes
27 Oct 2025
Mirvat Alasnag interviews Michael J. Mack on the PARTNER 3 Low-Risk randomised trial he presented at TCT 2025 in San Francisco.
Author
Author
Calcium modification and atherectomy
11 Oct 2025 – From AICT-AsiaPCR 2025
This session addresses the challenges of calcium modification and atherectomy in complex coronary interventions. It features case studies on stent deformation, advanced calcium modification strategies including orbital and laser atherectomy, imaging-guided approaches, and management of complications such as stent dislodgement, offering comprehensive insights into contemporary techniques...
Valve and structural: challenges and innovations
11 Oct 2025 – From AICT-AsiaPCR 2025
This session explores innovative approaches and challenges in valve and structural interventions, including expanding transcatheter techniques for ruptured sinus of Valsalva closure and prophylactic chimney stenting in high-risk TAVI patients. It also presents long-term outcomes of left main PCI according to stenting methods, comparative strategies in...
Unusual and high-stakes interventions
11 Oct 2025 – From AICT-AsiaPCR 2025
This session presents a series of unusual and high-stakes interventional cardiology cases that challenge conventional approaches. It includes critical scenarios such as narrow escapes from fatal outcomes, innovative solutions like complete percutaneous repair of adult tetralogy of Fallot, and management of valve complications, providing valuable insights...
